• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pandemic A/H1N1 influenza vaccination during pregnancy: A comparative study using the EFEMERIS database

tetano

Editor, Senior Moderator
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00053-X. doi: 10.1016/j.vaccine.2014.01.021. [Epub ahead of print]
Pandemic A/H1N1 influenza vaccination during pregnancy: A comparative study using the EFEMERIS database.
Beau AB1, Hurault-Delarue C2, Vidal S3, Guitard C4, Vayssi?re C5, Petiot D6, Montastruc JL2, Damase-Michel C2, Lacroix I2.
Author information
Abstract
OBJECTIVE:

To evaluate the risk of adverse pregnancy outcomes following A/H1N1 vaccination in pregnant women.
METHODS:

This observational cohort study compared vaccinated and non-vaccinated pregnant women in EFEMERIS, a French prescription database including pregnant women. Women who ended their pregnancy in South Western France between October 21, 2009 and November 30, 2010 (the period of the French vaccination campaign) were included. Two non-vaccinated women were individually matched to each vaccinated woman by month and year of pregnancy onset. Conditional logistic regression and Cox proportional hazards regression were used to evaluate associations between each outcome (all-cause pregnancy loss, preterm delivery, small for gestational age (SGA) and neonatal pathology) and A/H1N1 vaccination during pregnancy.
RESULTS:

1645 women of the 12,120 (13.6%) in the database who were administered A/H1N1 vaccine during pregnancy were compared to 3290 non-vaccinated women. Most were vaccinated in December 2009 (61%) with a non-adjuvanted vaccine (93%). The risks of pregnancy loss (adjusted HR=0.56; 95% CI=0.31-1.01), of preterm birth (adjusted HR=0.82; 95% CI=0.64-1.06), and of neonatal pathology (adjusted OR=0.70; 95% CI=0.49-1.02) did not differ between the vaccinated and the non-vaccinated groups. The rate of SGA was lower in the vaccinated group than in the non-vaccinated group (0.5% vs. 1.4%; adjusted OR=0.36; 95% CI=0.17-0.78).
CONCLUSION:

There was no significant association between adverse pregnancy outcomes and vaccination with a non-adjuvanted A/H1N1 vaccine during pregnancy.

Copyright ? 2014. Published by Elsevier Ltd.
KEYWORDS:

Adverse fetal outcomes, EFEMERIS, Influenza A(H1N1), Pregnancy, Vaccination

PMID:
24486369
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24486369
 
Back
Top Bottom